Novel immunosuppressant improves kidney function and quality of life after transplantationOctober 24, 2026
General Novel immunosuppressant improves kidney function and quality of life after transplantationBy Healthcare Propulsion StaffOctober 24, 20260 The Phase 2 BESTOW clinical trial showed that tegoprubart (a novel anti-CD40L antibody therapy) was better at preserving kidney function…
